These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 37545154

  • 1. Si-Ni-San Ameliorates the Clinical Symptoms of Interstitial Cystitis/Bladder Pain Syndrome in Rats by Decreasing the Expression of Inflammatory Factors.
    Yang Y, Shi Z, Yu H, Liu M, Hu T, Han C.
    Arch Esp Urol; 2023 Jul; 76(5):347-356. PubMed ID: 37545154
    [Abstract] [Full Text] [Related]

  • 2. [Optimization study of an animal model for interstitial cystitis/bladder pain syndrome based on the dose effect of cyclophosphamide].
    Ke H, Wang Q, Xu K.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Oct 18; 56(5):908-912. PubMed ID: 39397473
    [Abstract] [Full Text] [Related]

  • 3. Houttuynia cordata Extract Ameliorates Bladder Damage and Improves Bladder Symptoms via Anti-Inflammatory Effect in Rats with Interstitial Cystitis.
    Li W, Yang F, Zhan H, Liu B, Cai J, Luo Y, Zhou X.
    Evid Based Complement Alternat Med; 2020 Oct 18; 2020():9026901. PubMed ID: 33133219
    [Abstract] [Full Text] [Related]

  • 4. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
    Shah AM, Vodovotz Y, Yoshimura N, Chermansky CJ, Fitzgerald J, Tyagi P.
    Neurourol Urodyn; 2023 Nov 18; 42(8):1839-1848. PubMed ID: 37587846
    [Abstract] [Full Text] [Related]

  • 5. The serotonin(5-HT)2A receptor is involved in the hypersensitivity of bladder afferent neurons in cyclophosphamide-induced cystitis.
    Chen X, Lv R, Li M, Zhang L, Sun Y, Cao N, Gu B.
    Eur J Pharmacol; 2024 Nov 05; 982():176909. PubMed ID: 39154826
    [Abstract] [Full Text] [Related]

  • 6. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E, Impellizzeri D, Cervigni M, Porru D, Sommariva M, Cordaro M, Siracusa R, Fusco R, Gugliandolo E, Crupi R, Schievano C, Inferrera A, Di Paola R, Cuzzocrea S, Urology Study Group.
    Pharmacol Res; 2018 Aug 05; 134():16-30. PubMed ID: 29800607
    [Abstract] [Full Text] [Related]

  • 7. Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal.
    Fang W, Song Q, Lv T, Lv J, Cai Z, Wang Z, Song X, Ji X, Huang J.
    Int Urol Nephrol; 2023 Dec 05; 55(12):3065-3075. PubMed ID: 37594700
    [Abstract] [Full Text] [Related]

  • 8. Identification of key pathways and mRNAs in interstitial cystitis/bladder pain syndrome treatment with quercetin through bioinformatics analysis of mRNA-sequence data.
    Wang G, Li P, Su SW, Xu R, Huang ZY, Yang TX, Li JM.
    Aging (Albany NY); 2024 Mar 22; 16(7):5949-5966. PubMed ID: 38526326
    [Abstract] [Full Text] [Related]

  • 9. Phloroglucinol protects the urinary bladder via inhibition of oxidative stress and inflammation in a rat model of cyclophosphamide-induced interstitial cystitis.
    He YQ, Zhang WT, Shi CH, Wang FM, Tian XJ, Ma LL.
    Chin Med J (Engl); 2015 Apr 05; 128(7):956-62. PubMed ID: 25836618
    [Abstract] [Full Text] [Related]

  • 10. Activation of translocator protein alleviates mechanical allodynia and bladder dysfunction in cyclophosphamide-induced cystitis through repression of BDNF-mediated neuroinflammation.
    Huang Y, Su M, Zhang C, Zhan H, Yang F, Gao Z, Zhou X, Liu B.
    Eur J Pain; 2022 Jul 05; 26(6):1234-1244. PubMed ID: 35293071
    [Abstract] [Full Text] [Related]

  • 11. Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis.
    de Oliveira MG, Mónica FZ, Calmasini FB, Alexandre EC, Tavares EBG, Soares AG, Costa SKP, Antunes E.
    Am J Physiol Renal Physiol; 2018 Sep 01; 315(3):F460-F468. PubMed ID: 29717937
    [Abstract] [Full Text] [Related]

  • 12. Decreased autophagic activity of detrusor cells is involved in the inflammatory response of interstitial cystitis/bladder pain syndrome.
    Zhao J, Lu Q, Yang Z, Sun B, Zhu J, Zhang H, Yang C, Yi S, Dong X.
    Int Urogynecol J; 2023 Apr 01; 34(4):843-851. PubMed ID: 35689690
    [Abstract] [Full Text] [Related]

  • 13. Elucidation of the pathophysiology of interstitial cystitis/bladder pain syndrome via experimental autoimmune cystitis rat model.
    Kadekawa K, Nishijima S, Noguchi K, Matsumoto S, Sugaya K.
    Am J Physiol Regul Integr Comp Physiol; 2024 Aug 01; 327(2):R250-R260. PubMed ID: 38842512
    [Abstract] [Full Text] [Related]

  • 14. Normalization of magnesium deficiency attenuated mechanical allodynia, depressive-like behaviors, and memory deficits associated with cyclophosphamide-induced cystitis by inhibiting TNF-α/NF-κB signaling in female rats.
    Chen JL, Zhou X, Liu BL, Wei XH, Ding HL, Lin ZJ, Zhan HL, Yang F, Li WB, Xie JC, Su MZ, Liu XG, Zhou XF.
    J Neuroinflammation; 2020 Apr 02; 17(1):99. PubMed ID: 32241292
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic Effects of AF219 on Interstitial Cystitis/Bladder Pain Syndrome Induced by Cyclophosphamide or Water Avoidance Stress in Rats.
    Avci IE, Teke K, Gocmez SS, Kasap M, Akpinar G, Yaprak Bayrak B, Celebi G, Sarihan M, Utkan T, Ozkurkcugil C.
    Int Urogynecol J; 2024 Mar 02; 35(3):677-688. PubMed ID: 38376547
    [Abstract] [Full Text] [Related]

  • 16. Trypsin-induced elevated contractile responses in a rat model of interstitial cystitis/bladder pain syndrome: Involvement of PAR2 and intracellular Ca2+ release pathways.
    Denizalti M, Anjum I, Simsek G, Onder SC, Durlu-Kandilci NT.
    Life Sci; 2022 Mar 15; 293():120359. PubMed ID: 35092732
    [Abstract] [Full Text] [Related]

  • 17. Hispidulin targets PTGS2 to improve cyclophosphamide-induced cystitis by suppressing NLRP3 inflammasome.
    Liu S, Li S, Dong Y, Qiao K, Zhao Y, Yu J.
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug 15; 397(8):5819-5830. PubMed ID: 38321213
    [Abstract] [Full Text] [Related]

  • 18. Divergent histopathological and molecular patterns in chemically induced interstitial cystitis/bladder pain syndrome rat models.
    Chang YC, Yu CY, Dong C, Chen SL, Sung WW.
    Sci Rep; 2024 Jul 12; 14(1):16134. PubMed ID: 38997336
    [Abstract] [Full Text] [Related]

  • 19. The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.
    Xiao H, Wang T, Gao B, Liu J, Li S, Ma J.
    Neurourol Urodyn; 2024 Mar 12; 43(3):754-766. PubMed ID: 38356381
    [Abstract] [Full Text] [Related]

  • 20. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
    Liu BK, Jin XW, Lu HZ, Zhang X, Zhao ZH, Shao Y.
    Inflammation; 2019 Feb 12; 42(1):246-254. PubMed ID: 30196377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.